약물유전체학 시장(2024-2028년)
약물유전체학 시장은 2023-2028년 21억 9,670만 달러로 예측되며, 예측 기간 동안 연평균 6.2%의 성장률을 보일 것으로 예상됩니다. 이 보고서는 파머코유전체학 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.
현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 유전성 질환 및 장애의 유병률 증가, 첨단 약물유전체학 검사 제품의 승인 증가, 유전자 검사 비용의 감소로 인한 가격의 경제성 증가가 시장 성장을 견인하고 있습니다.
| 시장 범위 |
| 기준 연도 |
2024년 |
| 종료 연도 |
2028년 |
| 예측 기간 |
2024-2028년 |
| 성장 모멘텀 |
가속 |
| 전년 대비[2024년] |
5.7% |
| CAGR |
6.2% |
| 증분 금액 |
21억 9,670만 달러 |
이 보고서는 향후 몇 년간 약물유전체학 시장의 성장을 촉진하는 주요 요인 중 하나로 조기 질병 진단을 위한 소비자 직접 유전자 검사의 채택이 확대될 것으로 예상하고 있습니다. 또한, 차세대 시퀀싱의 발전과 약물 부작용을 줄이기 위한 약물유전체학 검사의 채택 확대도 시장 수요를 견인할 것으로 보입니다.
목차
제1장 주요 요약
제2장 Technavio 분석
- 가격·수명주기·고객 구입 바스켓·채용률·구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 상황
제4장 시장 규모
- 시장 정의
- 시장 부문 분석
- 시장 규모 2023년
- 시장 전망 2023-2028년
제5장 시장 규모 실적
- 약물유전체학 세계 시장 2018-2022년
- 최종사용자별 부문 분석 2018-2022년
- 지역별 부문 분석 2018-2022년
- 국가별 부문 분석 2018-2022년
제6장 정성 분석
제7장 Five Forces 분석
- Five Forces 요약
- 구매자의 교섭력
- 공급 기업의 교섭력
- 신규 참여업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 상황
제8장 시장 세분화 : 최종사용자별
- 시장 부문
- 비교 : 최종사용자별
- 병원과 클리닉 : 시장 규모와 예측 2023-2028년
- 연구기관 : 시장 규모와 예측 2023-2028년
- 학술기관 : 시장 규모와 예측 2023-2028년
- 시장 기회 : 최종사용자별
제9장 고객 상황
제10장 지역별 상황
- 지역별 세분화
- 비교 : 지역별
- 북미 : 시장 규모와 예측 2023-2028년
- 유럽 : 시장 규모와 예측 2023-2028년
- 아시아 : 시장 규모와 예측 2023-2028년
- 기타 : 시장 규모와 예측 2023-2028년
- 미국 : 시장 규모와 예측 2023-2028년
- 캐나다 : 시장 규모와 예측 2023-2028년
- 독일 : 시장 규모와 예측 2023-2028년
- 영국 : 시장 규모와 예측 2023-2028년
- 프랑스 : 시장 규모와 예측 2023-2028년
- 이탈리아 : 시장 규모와 예측 2023-2028년
- 중국 : 시장 규모와 예측 2023-2028년
- 일본 : 시장 규모와 예측 2023-2028년
- 인도 : 시장 규모와 예측 2023-2028년
- 한국 : 시장 규모와 예측 2023-2028년
- 지역 상황에 의한 시장 기회
제11장 촉진요인, 과제, 기회, 억제요인
- 시장 성장 촉진요인
- 시장 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회·억제요인
제12장 경쟁 구도
제13장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- Abbott Laboratories
- Admera Health
- ATS GENETECH PVT. LTD.
- Dynamic DNA Laboratories
- geneOmbio Technologies Pvt. Ltd.
- Mesa Laboratories Inc.
- Myriad Genetics Inc.
- OneOme LLC
- Thermo Fisher Scientific Inc.
제14장 부록
ksm
Pharmacogenomics Market 2024-2028
The pharmacogenomics market is forecasted to grow by USD 2196.7 mn during 2023-2028, accelerating at a CAGR of 6.2% during the forecast period. The report on the pharmacogenomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of genetic diseases and disorders, rising approval of advanced pharmacogenomics testing products, and increasing affordability due to reduction in cost of genetic testing.
| Market Scope |
|---|
| Base Year | 2024 |
| End Year | 2028 |
| Series Year | 2024-2028 |
| Growth Momentum | Accelerate |
| YOY 2024 | 5.7% |
| CAGR | 6.2% |
| Incremental Value | $2196.7 mn |
Technavio's pharmacogenomics market is segmented as below:
By End-user
- Hospitals and clinics
- Research organizations
- Academic
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing adoption of direct-to-consumer genetic tests in early disease diagnosis as one of the prime reasons driving the pharmacogenomics market growth during the next few years. Also, advancements in next-generation sequencing and growing adoption of pharmacogenomics testing in reducing adverse drug events will lead to sizable demand in the market.
The report on the pharmacogenomics market covers the following areas:
- Pharmacogenomics Market sizing
- Pharmacogenomics Market forecast
- Pharmacogenomics Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmacogenomics market vendors that include 23andMe Holding Co., Abbott Laboratories, Admera Health, ATS GENETECH PVT. LTD., Dynamic DNA Laboratories, geneOmbio Technologies Pvt. Ltd., Illumina Inc., Laboratory Corp. of America Holdings, Mesa Laboratories Inc., Myriad Genetics Inc., OneOme LLC, OPKO Health Inc., QIAGEN N.V., Quest Diagnostics Inc., and Thermo Fisher Scientific Inc.. Also, the pharmacogenomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2023
- 4.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
5 Historic Market Size
- 5.1 Global Pharmacogenomics Market 2018 - 2022
- Historic Market Size - Data Table on Global Pharmacogenomics Market 2018 - 2022 ($ million)
- 5.2 End-user segment analysis 2018 - 2022
- Historic Market Size - End-user Segment 2018 - 2022 ($ million)
- 5.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 5.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Pharmacogenomics Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 7.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by End-user
- 8.1 Market segments
- Chart on End-user - Market share 2023-2028 (%)
- Data Table on End-user - Market share 2023-2028 (%)
- 8.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 8.3 Hospitals and clinics - Market size and forecast 2023-2028
- Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
- 8.4 Research organizations - Market size and forecast 2023-2028
- Chart on Research organizations - Market size and forecast 2023-2028 ($ million)
- Data Table on Research organizations - Market size and forecast 2023-2028 ($ million)
- Chart on Research organizations - Year-over-year growth 2023-2028 (%)
- Data Table on Research organizations - Year-over-year growth 2023-2028 (%)
- 8.5 Academic - Market size and forecast 2023-2028
- Chart on Academic - Market size and forecast 2023-2028 ($ million)
- Data Table on Academic - Market size and forecast 2023-2028 ($ million)
- Chart on Academic - Year-over-year growth 2023-2028 (%)
- Data Table on Academic - Year-over-year growth 2023-2028 (%)
- 8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
9 Customer Landscape
- 9.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Geographic Landscape
- 10.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
- 10.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 10.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 10.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 10.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 10.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 10.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 10.8 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
- 10.9 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 10.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 10.11 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
- 10.12 Italy - Market size and forecast 2023-2028
- Chart on Italy - Market size and forecast 2023-2028 ($ million)
- Data Table on Italy - Market size and forecast 2023-2028 ($ million)
- Chart on Italy - Year-over-year growth 2023-2028 (%)
- Data Table on Italy - Year-over-year growth 2023-2028 (%)
- 10.13 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 10.14 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 10.15 India - Market size and forecast 2023-2028
- Chart on India - Market size and forecast 2023-2028 ($ million)
- Data Table on India - Market size and forecast 2023-2028 ($ million)
- Chart on India - Year-over-year growth 2023-2028 (%)
- Data Table on India - Year-over-year growth 2023-2028 (%)
- 10.16 South Korea - Market size and forecast 2023-2028
- Chart on South Korea - Market size and forecast 2023-2028 ($ million)
- Data Table on South Korea - Market size and forecast 2023-2028 ($ million)
- Chart on South Korea - Year-over-year growth 2023-2028 (%)
- Data Table on South Korea - Year-over-year growth 2023-2028 (%)
- 10.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
11 Drivers, Challenges, and Opportunity/Restraints
- 11.1 Market drivers
- 11.2 Market challenges
- 11.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 11.4 Market opportunities/restraints
12 Competitive Landscape
- 12.1 Overview
- 12.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 12.3 Landscape disruption
- Overview on factors of disruption
- 12.4 Industry risks
- Impact of key risks on business
13 Competitive Analysis
- 13.1 Companies profiled
- 13.2 Company ranking index
- 13.3 Market positioning of companies
- Matrix on companies position and classification
- 23andMe Holding Co.
- 23andMe Holding Co. - Overview
- 23andMe Holding Co. - Business segments
- 23andMe Holding Co. - Key offerings
- 23andMe Holding Co. - Segment focus
- SWOT
- 13.5 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 13.6 Admera Health
- Admera Health - Overview
- Admera Health - Product / Service
- Admera Health - Key offerings
- SWOT
- 13.7 ATS GENETECH PVT. LTD.
- ATS GENETECH PVT. LTD. - Overview
- ATS GENETECH PVT. LTD. - Product / Service
- ATS GENETECH PVT. LTD. - Key offerings
- SWOT
- 13.8 Dynamic DNA Laboratories
- Dynamic DNA Laboratories - Overview
- Dynamic DNA Laboratories - Product / Service
- Dynamic DNA Laboratories - Key offerings
- SWOT
- 13.9 geneOmbio Technologies Pvt. Ltd.
- geneOmbio Technologies Pvt. Ltd. - Overview
- geneOmbio Technologies Pvt. Ltd. - Product / Service
- geneOmbio Technologies Pvt. Ltd. - Key offerings
- SWOT
- 13.10 Mesa Laboratories Inc.
- Mesa Laboratories Inc. - Overview
- Mesa Laboratories Inc. - Business segments
- Mesa Laboratories Inc. - Key offerings
- Mesa Laboratories Inc. - Segment focus
- SWOT
- 13.11 Myriad Genetics Inc.
- Myriad Genetics Inc. - Overview
- Myriad Genetics Inc. - Product / Service
- Myriad Genetics Inc. - Key news
- Myriad Genetics Inc. - Key offerings
- SWOT
- 13.12 OneOme LLC
- OneOme LLC - Overview
- OneOme LLC - Product / Service
- OneOme LLC - Key offerings
- SWOT
- 13.13 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
14 Appendix
- 14.1 Scope of the report
- 14.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 14.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 14.4 Research methodology
- 14.5 Data procurement
- 14.6 Data validation
- 14.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 14.8 Data synthesis
- 14.9 360 degree market analysis
- 360 degree market analysis
- 14.10 List of abbreviations
